×
0 0.00806451612903223 0.00806451612903223 0.014616935483871 0.015625 0.0221774193548387 0.0201108870967742 0.0241935483870968
Stockreport

J.P. Morgan analyst crowns Bluebird Bio the ‘clear winner’ at major cancer conference [MarketWatch]

BLUEBIRD BIO (BLUE)  More Company Research Source: MarketWatch
Last bluebird bio earnings: 5/2 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF J.P. Morgan analyst crowns Bluebird Bio the ‘clear winner’ at major cancer conference Early positive results for the biotech company Bluebird Bio’s cancer drug have prompted a J.P. Morgan analyst to christen the company “the clear winner this weekend,” referencing the American Society of Clinical Oncology’s annual meeting, which ran Friday to Tuesday. The trial results have also led to tangible gains for the company’s stock BLUE, +7.56% or a nearly 20% increase since shares closed at $84.15 on Friday. The title and stock moves followed positive results for an ongoing early-stage clinical trial looking at Bluebird’s bb2121 in patients with relapsed/refractory multiple myeloma. The drug is being developed in partnership with Celgene Corp. CELG, -1.03% Read: Bluebird Bio stock rises 7.4% on positive data from ongoing early-stage clinical trial Of four groups of patients at different dosage levels, three of those groups had an overall response rate of 100%. (The other group had [Read more]

IMPACT SNAPSHOT EVENT TIME: BLUE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS